Abstract
Gemfibrozil (CI-719) has proved to be an effective agent in reducing the plasma triglyceride levels in experimental animals and in patients with endogenous hypertriglyceridaemia. We have confirmed these findings.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adams P. W., Kissebah A. H., Harrigan P., Stokes T., Wynn V. The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridaemia and their relation to carbohydrate metabolism. Eur J Clin Invest. 1974 Jun;4(3):149–161. doi: 10.1111/j.1365-2362.1974.tb00386.x. [DOI] [PubMed] [Google Scholar]
- Barter P. J., Nestel P. J., Carroll K. F. Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver. Metabolism. 1972 Feb;21(2):117–124. doi: 10.1016/0026-0495(72)90063-7. [DOI] [PubMed] [Google Scholar]
- Barter P. J., Nestel P. J. Precursors of plasma triglyceride fatty acids in obesity. Metabolism. 1973 Jun;22(6):779–783. doi: 10.1016/0026-0495(73)90048-6. [DOI] [PubMed] [Google Scholar]
- Eisenberg S., Rachmilewitz D. Metabolism of rat plasma very low density lipoprotein. I. Fate in circulation of the whole lipoprotein. Biochim Biophys Acta. 1973 Dec 20;326(3):378–390. doi: 10.1016/0005-2760(73)90139-2. [DOI] [PubMed] [Google Scholar]
- Kissebah A. H., Adams P. W., Harrigan P., Wynn V. The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia. Eur J Clin Invest. 1974 Jun;4(3):163–174. doi: 10.1111/j.1365-2362.1974.tb00387.x. [DOI] [PubMed] [Google Scholar]
- Kissebah A. H., Adams P. W., Wynn V. Plasma free fatty acid and triglyceride transport kinetics in man. Clin Sci Mol Med. 1974 Sep;47(3):259–278. doi: 10.1042/cs0470259. [DOI] [PubMed] [Google Scholar]
- Kissebah A. H., Alfarsi S., Adams P. W., Seed M., Folkard J., Wynn V. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy. Atherosclerosis. 1976 Jul-Aug;24(1-2):199–218. doi: 10.1016/0021-9150(76)90076-9. [DOI] [PubMed] [Google Scholar]
- Kissebah A. H., Alfarsi S., Adams P. W., Wynn V. The metabolic fate of plasma lipoproteins in normal subjects and in patients with insulin resistance and endogenous hypertriglyceridaemia. Diabetologia. 1976 Oct;12(5):501–509. doi: 10.1007/BF01219515. [DOI] [PubMed] [Google Scholar]